Japanese Generic Market Forecast to 2013

Table of Contents

1. Analyst View

2. The Japanese Pharmaceutical Market

• 2.1 Country Snapshot
• 2.2 Market Trend Analysis
• 2.3 Price Cuts by Government
• 2.4 Therapy Area Analysis
• 2.5 Market Share of Key Players
• 2.6 Market Forecast till 2013

3. What is Making Generics So Lucrative in Japan

• 3.1 Pressure on Government to Cut Skyrocketing Healthcare Costs
• 3.2 Generic Market is a large "Untapped Goldmine"
• 3.3 Margin from Generics is Fairly Higher than Other Developed Markets
• 3.4 Major Blockbusters Going Off-patent
• 3.5 Increasing Investment by Major Domestic and Foreign Companies

4. The Japanese Generic Market

• 4.1 Market Trend Analysis
• 4.2 Generics Substitution has been Slow so Far
• 4.3 Regulatory Changes and Incentives will Lead to Rapid Adoption in Future
• 4.4 US and European Generics Strategies will Fail in Japan
• 4.5 Perception about Generics is a Significant Barrier
• 4.6 Market Share of Key Players
• 4.7 Market Forecast till 2013

5. Key Players

• 5.1 Sawai Pharmaceuticals
• 5.2 Taiyo Pharmaceutical
• 5.3 Nichi-Iko
• 5.4 Towa
• 5.5 Nippon Chemiphar
• 5.6 Fuji Pharma

List of Figures:

• Figure 2-1: Japan - Leading Causes of Death (%), 2005 & 2030
• Figure 2-2: Japan - Sources of Healthcare Financing (%), 2005
• Figure 2-3: Japan - Pharmaceutical Market (in Trillion ¥), FY 2003 to FY 2008
• Figure 2-4: Japan - NHI Price Cuts in Pharmaceutical Market (%), 1994 to 2008
• Figure 2-5: Japan - Forecast for Pharmaceutical Market (in Trillion ¥), FY 2009 to FY 2013
• Figure 3-1: Japan - Population Aged 65 Years & Above (in Million), 2003-2008
• Figure 3-2: Japan - Forecast for Population Aged 65 Years & Above (in Million), 2009-2013
• Figure 3-3: Japan - Healthcare Expenditure and Revenue of NHI (in Trillion ¥). 2005, 2020 & 2035
• Figure 3-4: Japan - Share of Generics in Pharmaceutical Market w.r.t Top Seven Markets
• Figure 3-5: Japan - Cost of Generics w.r.t Other Countries
• Figure 3-6: Japan - Drug Patent Expiry Cost (in Billion ¥), 2007 & 2008
• Figure 4-1: Japan - Generic Market (in Billion ¥), 2005-2008
• Figure 4-2: Japan - Generic Market by Manufacturer (%), 2007
• Figure 4-3: Japan - Forecast for Generic Market (in Billion ¥), 2009-2013
• Figure 4-4: Japan - Share of Generics in Pharmaceutical Market (%), 2006 & FY 2012

List of Tables:

• Table 2-1: Japan - Key Macroeconomic Indicators (2003-2008)
• Table 2-2: Japan - Forecast for Key Macroeconomic Indicators (2009-2013)
• Table 2-3: Japan - Key Demographic and Healthcare Indicators (2003-2008)
• Table 2-4: Japan - Forecast for Key Demographic and Healthcare Indicators (2009-2013)
• Table 2-5: Japan - Healthcare Spending Statistics (2003-2008)
• Table 2-6: Japan - Forecast for Healthcare Spending Statistics (2009-2013)
• Table 2-7: Japan - Sources of Pharmaceutical Purchases (in Billion ¥), FY 2007
• Table 2-8: Japan - Statistics of Top 10 Therapy Areas (FY 2007)
• Table 2-9: Japan - Statistics of Top 20 Pharmaceutical Players (2007)
• Table 2-10: Japan - Key Driving and Restraining Factors in Pharmaceutical Market
• Table 4-1: Japan - Extent of Awareness, Consideration, Request and Prescription in Generic Market (2006)
• Table 4-2: Japan - Key Driving and Restraining Factors in Generic Market